跳至主要内容
临床试验/IRCT2013121915863N1
IRCT2013121915863N1已完成2 期

Assesment of the effect of supplemental aqueous extracts of Achillea milefolium on the symptoms, severity and memory deficits in Rafsanjan Multiple sclerosis patients

Rafsanjan University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 55 years(—)
性别
All

入选标准

  • Inclusion criteria were an age of 16 to 55 years; a diagnosis of multiple sclerosis, according to the revised McDonald criteria; a relapsing–remitting course; one or more documented relapses in the previous year or two or more in the previous 2 years; and a score of 0 to 5.5 on the EDSS. exclusion criteria were relapse or corticosteroid treatment within 30 days before randomization, active infection, or clinically significant systemic disease.

排除标准

  • 未提供

研究者

相似试验